Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hadasit Bio HoldingsHSITF 14 EV-to-EBITDA is -0.99 as of Aug. 14, 2026. GuruFocus rates HSITF with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 400 Biotechnology companies, Hadasit Bio Holdings ranks worse than 249999.75% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Hadasit Bio Holdings's enterprise value is $0.57 Mil.
Hadasit Bio Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.58 Mil. Therefore, Hadasit Bio Holdings's EV-to-EBITDA for today is -0.99.
The historical rank and industry rank for Hadasit Bio Holdings's EV-to-EBITDA or its related term are showing as below:
HSITF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.98 Med: -0.56 Max: 2.61
Current: -3.97
During the past 13 years, the highest EV-to-EBITDA of Hadasit Bio Holdings was 2.61. The lowest was -15.98. And the median was -0.56.
HSITF's EV-to-EBITDA is ranked worse than 100% of 400
companies
in the Biotechnology industry
Industry Median: 13.485
vs HSITF: -3.97
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Hadasit Bio Holdings (OTCPK:HSITF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hadasit Bio Holdings's PE Ratio (TTM) for today is calculated as:
Hadasit Bio Holdings's share price for today is $0.12.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hadasit Bio Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.027.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Hadasit Bio Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HSITF vs VRTX, REGN, RVMD: EV-to-EBITDA Comparison
For the Biotechnology subindustry, Hadasit Bio Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hadasit Bio Holdings EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hadasit Bio Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Hadasit Bio Holdings's EV-to-EBITDA falls into.
Hadasit Bio Holdings's current Enterprise Value is $0.57 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hadasit Bio Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hadasit Bio Holdings (HSITF) has a EV-to-EBITDA of -0.99 as of Aug. 14, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Hadasit Bio Holdings. According to the industry distribution chart, Hadasit Bio Holdings ranks #999999 out of 400 companies in the Biotechnology industry.
Is Hadasit Bio Holdings' EV-to-EBITDA too high?
Hadasit Bio Holdings' current EV-to-EBITDA is -0.99. Based on the distribution chart, Hadasit Bio Holdings ranks #999999 out of 400 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Hadasit Bio Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Hadasit Bio Holdings' EV-to-EBITDA compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hadasit Bio Holdings ranks #999999 out of 400 companies for EV-to-EBITDA. This places Hadasit Bio Holdings in the lower half of its industry. The industry median EV-to-EBITDA is 13.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 13.49, based on 400 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Hadasit Bio Holdings. For the Biotechnology industry, the median EV-to-EBITDA is 13.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hadasit Bio Holdings's current EV-to-EBITDA is -0.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hadasit Bio Holdings stock overvalued right now?
Hadasit Bio Holdings (HSITF) has a current EV-to-EBITDA of -0.99. The current EV-to-EBITDA is -0.99. Hadasit Bio Holdings' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Hadasit Bio Holdings (HSITF), the current EV-to-EBITDA is -0.99 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hadasit Bio Holdings Ltd serves as a precedent in the field of biotech financing. It is engaged in the advancement and enhancement of its portfolio companies. Its portfolio companies are involved in the field of medical and biotechnological research and production and distribution of the results of the research and development done in these areas.
14GF Score
Get the complete analysis for HSITF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSITF has been successfully added to your 
